"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Case report
peer-reviewed

Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer



Abstract

Radiation therapy is a well-established palliative treatment for symptomatic metastases from breast cancer. This is also true of symptomatic primary breast tumors in patients with metastatic disease or in those who are medically inoperable. Further, local progression in the chest wall can severely impair quality of life, with local pain, bleeding, and significant impact on one’s self-image. Here, we present the case of a patient who showed an exceptional response to a palliative hypofractionated radiation course to her bleeding, fungating breast primary.



Want to read more?

Create a free account to continue reading this article.

Already a member? Login.



Case report
peer-reviewed

Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer


Author Information

Kevin Quackenbush Corresponding Author

Department of Radiation Oncology, University of Colorado School of Medicine

Arya Amini

Department of Radiation Oncology, University of Colorado School of Medicine

Christine M. Fisher

Department of Radiation Oncology, University of Colorado School of Medicine

Rachel Rabinovitch

Department of Radiation Oncology, University of Colorado School of Medicine


Ethics Statement and Conflict of Interest Disclosures

Human subjects: Consent was obtained by all participants in this study. Conflicts of interest: The authors have declared that no conflicts of interest exist.


Case report
peer-reviewed

Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer


Figures etc.

Share
Case report
peer-reviewed

Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer

  • Author Information
    Kevin Quackenbush Corresponding Author

    Department of Radiation Oncology, University of Colorado School of Medicine

    Arya Amini

    Department of Radiation Oncology, University of Colorado School of Medicine

    Christine M. Fisher

    Department of Radiation Oncology, University of Colorado School of Medicine

    Rachel Rabinovitch

    Department of Radiation Oncology, University of Colorado School of Medicine


    Ethics Statement and Conflict of Interest Disclosures

    Human subjects: Consent was obtained by all participants in this study. Conflicts of interest: The authors have declared that no conflicts of interest exist.

    Acknowledgements


    Article Information

    Published: July 02, 2017

    DOI

    10.7759/cureus.1417

    Cite this article as:

    Quackenbush K, Amini A, Fisher C M, et al. (July 02, 2017) Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer. Cureus 9(7): e1417. doi:10.7759/cureus.1417

    Publication history

    Received by Cureus: May 24, 2017
    Peer review began: May 31, 2017
    Peer review concluded: June 28, 2017
    Published: July 02, 2017

    Copyright

    © Copyright 2017
    Quackenbush et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    License

    This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Radiation therapy is a well-established palliative treatment for symptomatic metastases from breast cancer. This is also true of symptomatic primary breast tumors in patients with metastatic disease or in those who are medically inoperable. Further, local progression in the chest wall can severely impair quality of life, with local pain, bleeding, and significant impact on one’s self-image. Here, we present the case of a patient who showed an exceptional response to a palliative hypofractionated radiation course to her bleeding, fungating breast primary.



Want to read more?

Create a free account to continue reading this article.

Already a member? Login.



Kevin Quackenbush, Medical Student

Department of Radiation Oncology, University of Colorado School of Medicine

For correspondence:
kevin.quackenbush@ucdenver.edu

Arya Amini

Department of Radiation Oncology, University of Colorado School of Medicine

Christine M. Fisher

Department of Radiation Oncology, University of Colorado School of Medicine

Rachel Rabinovitch

Department of Radiation Oncology, University of Colorado School of Medicine

Kevin Quackenbush, Medical Student

Department of Radiation Oncology, University of Colorado School of Medicine

For correspondence:
kevin.quackenbush@ucdenver.edu

Arya Amini

Department of Radiation Oncology, University of Colorado School of Medicine

Christine M. Fisher

Department of Radiation Oncology, University of Colorado School of Medicine

Rachel Rabinovitch

Department of Radiation Oncology, University of Colorado School of Medicine